Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder.

cognition health-related quality of life mood neuromyelitis optica spectrum disorder

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
02 May 2022
Historique:
received: 24 02 2022
revised: 19 04 2022
accepted: 29 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Background: The frequency of cognitive impairment (CI) reported in neuromyelitis optica spectrum disorder (NMOSD) is highly variable, and its relationship with demographic and clinical characteristics is poorly understood. We aimed to describe the cognitive profile of NMOSD patients, and to analyse the cognitive differences according to their serostatus; furthermore, we aimed to assess the relationship between cognition, demographic and clinical characteristics, and other aspects linked to health-related quality of life (HRQoL). Methods: This cross-sectional study included 41 patients (median age, 44 years; 85% women) from 13 Spanish centres. Demographic and clinical characteristics were collected along with a cognitive z-score (Rao’s Battery) and HRQoL patient-centred measures, and their relationship was explored using linear regression. We used the Akaike information criterion to model which characteristics were associated with cognition. Results: Fourteen patients (34%) had CI, and the most affected cognitive domain was visual memory. Cognition was similar in AQP4-IgG-positive and -negative patients. Gender, mood, fatigue, satisfaction with life, and perception of stigma were associated with cognitive performance (adjusted R2 = 0.396, p < 0.001). Conclusions: The results highlight the presence of CI and its impact on HRQoL in NMOSD patients. Cognitive and psychological assessments may be crucial to achieve a holistic approach in patient care.

Identifiants

pubmed: 35629165
pii: jpm12050743
doi: 10.3390/jpm12050743
pmc: PMC9146457
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Medical Department of Roche Farma Spain
ID : ML41397

Références

Ann Neurol. 2013 Jan;73(1):65-76
pubmed: 23378324
Arq Neuropsiquiatr. 2013 Jun;71(6):357-61
pubmed: 23828523
Mult Scler Relat Disord. 2020 Nov;46:102542
pubmed: 33296965
Patient Prefer Adherence. 2021 Apr 12;15:713-719
pubmed: 33880015
J Neuroimmunol. 2018 May 15;318:97-102
pubmed: 29519720
Lancet. 2004 Dec 11-17;364(9451):2106-12
pubmed: 15589308
Qual Life Res. 2002 May;11(3):263-72
pubmed: 12074263
Neurology. 1991 May;41(5):685-91
pubmed: 2027484
Clin Neurol Neurosurg. 2020 Feb;189:105621
pubmed: 31790906
Mult Scler. 2003 Aug;9(4):393-6
pubmed: 12926845
Front Neurol. 2019 Jun 12;10:608
pubmed: 31258505
Neurology. 2015 Oct 27;85(17):1491-9
pubmed: 26423432
J Neurol Sci. 2016 Jan 15;360:4-9
pubmed: 26723962
Mult Scler. 2015 Dec;21(14):1839-46
pubmed: 25828756
Mult Scler. 2006 Apr;12(2):187-95
pubmed: 16629422
Mult Scler Relat Disord. 2017 Nov;18:225-229
pubmed: 29141815
Neurol Neuroimmunol Neuroinflamm. 2019 Jun 20;6(4):e580
pubmed: 31355316
Neurology. 2015 Jul 14;85(2):177-89
pubmed: 26092914
Sci Rep. 2017 Aug 23;7(1):9180
pubmed: 28835657
J Pers Assess. 1991 Aug;57(1):149-61
pubmed: 1920028
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
PLoS One. 2012;7(4):e33878
pubmed: 22509264
Arch Neurol. 2008 Jan;65(1):84-8
pubmed: 18195143
Mult Scler Relat Disord. 2021 Apr;49:102757
pubmed: 33486400
Brain. 2001 May;124(Pt 5):962-73
pubmed: 11335698
Brain Behav. 2020 Nov;10(11):e01842
pubmed: 33022898
Int J Behav Med. 2013 Sep;20(3):450-60
pubmed: 22639392
Eur J Neurol. 2011 Jun;18(6):836-41
pubmed: 21087360
Appl Neuropsychol Adult. 2017 Mar-Apr;24(2):183-189
pubmed: 27077687
Med Care. 1988 Jul;26(7):724-35
pubmed: 3393032
J Neuroimmunol. 2020 Jan 15;338:577110
pubmed: 31715457
J Neuroimmunol. 2018 Oct 15;323:49-52
pubmed: 30196833
Mayo Clin Proc. 2017 Apr;92(4):663-679
pubmed: 28385199
Noro Psikiyatr Ars. 2020 Apr 24;58(3):200-205
pubmed: 34526842
Mult Scler. 2016 Dec;22(14):1850-1858
pubmed: 26920380

Auteurs

Elisabet Lopez-Soley (E)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, 08036 Barcelona, Spain.

Jose E Meca-Lallana (JE)

Department of Neurology, Clinical Neuroimmunology Unit and Multiple Sclerosis CSUR, Hospital Universitario "Virgen de la Arrixaca", IMIB-Arrixaca, 30120 Murcia, Spain.

Sara Llufriu (S)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, 08036 Barcelona, Spain.

Yolanda Blanco (Y)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, 08036 Barcelona, Spain.

Rocío Gómez-Ballesteros (R)

Medical Department, Roche Farma, 28042 Madrid, Spain.

Jorge Maurino (J)

Medical Department, Roche Farma, 28042 Madrid, Spain.

Francisco Pérez-Miralles (F)

Department of Neurology, Unit of Neuroimmunology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.

Lucía Forero (L)

Department of Neurology, Hospital Universitario Puerta del Mar, 11009 Cadiz, Spain.

Carmen Calles (C)

Department of Neurology, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.

María L Martinez-Gines (ML)

Department of Neurology, Hospital Universitario Gregorio Marañón, 28007 Madrid, Spain.

Inés Gonzalez-Suarez (I)

Department of Neurology, Hospital Universitario Álvaro Cunqueiro, 36213 Vigo, Spain.

Sabas Boyero (S)

Department of Neurology, Hospital Universitario Cruces, 48903 Bilbao, Spain.

Lucía Romero-Pinel (L)

Department of Neurology, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.

Ángel P Sempere (ÁP)

Department of Neurology, Hospital General Universitario de Alicante, 03010 Alicante, Spain.

Virginia Meca-Lallana (V)

Department of Neurology, Hospital Universitario La Princesa, 28006 Madrid, Spain.

Luis Querol (L)

Department of Neurology, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.

Lucienne Costa-Frossard (L)

Department of Neurology, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.

Maria Sepulveda (M)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, 08036 Barcelona, Spain.

Elisabeth Solana (E)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, 08036 Barcelona, Spain.

Classifications MeSH